Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus ; day:5 ; month:5 ; year:2020 ; pages:1-22
Advances in therapy ; (5.5.2020), 1-22
- Urheber
-
Kinduryte Schorling, Ona
Clark, Douglas
Zwiener, Isabella
Kaspers, Stefan
Lee, Jisoo
Iliev, Hristo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-020-01329-7
- URN
-
urn:nbn:de:101:1-2020071222050790354661
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kinduryte Schorling, Ona
- Clark, Douglas
- Zwiener, Isabella
- Kaspers, Stefan
- Lee, Jisoo
- Iliev, Hristo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
Stress echocardiography: safety and tolerability
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12
Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
Stress echocardiography: safety and tolerability
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12
Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
Stress echocardiography: safety and tolerability
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12